2 studies found for:    alps, niaid | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Condition: Autoimmune Lymphproliferative Syndrome
Intervention:
2 Recruiting Evaluating the Safety and Immunogenicity of PENNVAX®-GP DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: PENNVAX®-GP HIV-1 DNA vaccine;   Biological: Interleukin-12 (IL-12) DNA adjuvant;   Biological: Placebo

Indicates status has not been verified in more than two years